Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tasman Global is a healthcare IT consulting company focused on helping hospitals and health systems navigate electronic health record (EHR) implementation, optimization, analytics, managed services, and broader digital transformation programs. The company built its business primarily around advisory and technical services for provider organizations in Europe and other international markets rather than around therapeutics or medical products. Tasman was acquired by Nordic in October 2020 and later transitioned to the Nordic brand in 2022, although Tasman-related legal entities and branding references have continued to appear in certain jurisdictions and compliance documents. For a biotech analyst, this is a healthcare-services and health-IT organization, not a drug-development biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tasman Global.